Notably, RUNX1’s broader role in tissue remodeling is evident in fibrotic diseases like systemic sclerosis (SSc), where hypomethylation-driven RUNX1 overexpression accelerates ECM dysregulation [15]. The gene discussed is RUNX1; the disease is systemic sclerosis.